(Q39608885)

13 September 2017

title

Development of stealth liposome coencapsulating doxorubicin and fluoxetine (English)

1 reference

13 September 2017

1 reference

Jasmine Chiat-Ling Ong

series ordinal

1

1 reference

13 September 2017

Feng Sun

series ordinal

2

1 reference

13 September 2017

Eli Chan

series ordinal

3

1 reference

13 September 2017

publication date

12 January 2011

1 reference

Journal of Liposome Research

13 September 2017

published in

1 reference

13 September 2017

volume

21

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

261-271

1 reference

An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Formation of transition metal-doxorubicin complexes inside liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

The liposomal formulation of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Stealth® liposomes: from theory to product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Liquid chromatographic determination of fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Drug interaction and location in liposomes: correlation with polar surface areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Drug ratio-dependent antagonism: a new category of multidrug resistance and strategies for its circumvention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Interaction of fluoxetine with phosphatidylcholine liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Cellular resistance to anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

In vitro cytotoxicity of Stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2010.545070

10.3109/08982104.2010.545070

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference